The GLP-1s include semaglutide (Ozempic, Wegovy) and the combination of GLP-1/GIP drug tirzepatide (Mounjaro, Zepbound).

The FDA has approved Steqeyma® (ustekinumab-stba), a biosimilar to Stelara®, for the treatment of various chronic ...

Topline data were announced from two phase 3 trials evaluating deucravacitinib in adults with active psoriatic arthritis.

Discover how both heat and cold can impact psoriatic arthritis symptoms and learn which is best for your relief.

These complications are often treatable with medication, lifestyle changes, or physical therapy and rarely with surgery. Psoriatic arthritis (PsA) most often attacks and damages joints in your ...

Chronic kidney disease is not uncommon among patients with PsA, with risk factors including diabetes and NSAID use, while ...

Bristol Myers Squibb (BMS) has shared positive top-line results from two late-stage studies of its oral TYK2 inhibitor Sotyktu (deucravacitinib) in adults with active psoriatic arthritis (PsA). The ...

Differences in how men and women manifest and experience psoriatic arthritis suggest it’s time to think of patient sex as a ...

Make your inbox healthier and happier with the latest SELF stories, delivered fresh daily.

Experts propose potential workarounds for obstacles to wider use of combined clinics and personalized medicine for ...

Introduction: The relationship between the phenotype and treatment of psoriatic arthritis (PsA) and the increased prevalence of cardiovascular comorbidities is not well studied. Objective: To assess ...